Health Universe

Based in the US, Health Universe provides AI-driven solutions to enhance clinical workflows, focusing on improving patient care through innovative technology in healthcare organizations. Health Universe, founded in 2023 and headquartered in San Francisco, US, specializes in AI solutions for healthcare. The company has received a total of USD 6. 00 mn in funding through 2 deals, with the most recent being a SEED round led by Kleiner Perkins on March 19, 2026.

Health Universe primarily offers a suite of AI-driven solutions designed to enhance clinical workflows within healthcare organizations. Their flagship product, Navigator, serves as a clinical assistant that integrates generative AI into existing processes, enabling real-time insights that streamline patient care. The platform facilitates the development, testing, and deployment of AI models tailored to a variety of clinical applications, addressing common challenges such as reducing administrative burdens and improving patient outcomes. Health Universe's client base includes healthcare providers, researchers, and administrators, with end users ranging from clinicians to health system executives who benefit from the efficiency and support Navigator provides.

The solutions are primarily marketed to healthcare organizations in North America, with a focus on ensuring compliance with HIPAA, SOC2, and ONC security standards. Health Universe generates revenue through a subscription-based model, providing access to its Navigator platform and associated AI services. Clients typically engage in annual contracts that grant them the ability to utilize the AI tools for improving operational efficiencies and enhancing clinical decision-making. The pricing structure varies based on the scope of services offered, including customization options for larger healthcare systems or collaborative partnerships with research institutions.

By integrating AI-driven clinical decision support and automating workflows, Health Universe positions its offerings as essential tools for healthcare organizations looking to optimize their operations and patient care outcomes. This transactional structure highlights the value placed on the AI solutions developed by Health Universe within the healthcare landscape. In March 2026, Health Universe raised USD 6 million in seed funding led by new investor Kleiner Perkins. The company will use the funding to scale its operations, expand its AI workflow platform, and deploy compliant AI agents across more healthcare organizations, with a focus on oncology and clinical research use cases.

Plans for market expansion include targeting new healthcare organizations in North America, aiming to introduce its innovative solutions by the end of 2027.